Some three years after the University of Pennsylvania claimed four of Roche’s breast cancer meds infringed its intellectual ...

Cancer research saved my daughter’s life, and despite setbacks, we must support these efforts to ensure more lives are saved ...

Novel HER2 therapies show strong intracranial efficacy, enabling systemic treatment over local therapy for small, ...

Antibody-drug conjugates (ADCs) are new drugs that combine a monoclonal antibody with a chemotherapy drug. They can specifically target cancer cells to deliver potent chemotherapy drugs.

The global breast cancer drugs market size was valued at USD 34.25 billion in 2024 and is projected to reach from USD 37.30 ...

Subcutaneous administration of trastuzumab and pertuzumab significantly shortened the time patients with stage I ...

Death rates from breast cancer will fall in 2025 in every age group in the EU and the UK apart from in EU patients aged 80 ...

A drug which prolongs the life of women with a certain type of breast cancer was finally made available on the NHS today. Herceptin can lengthen the life of women with HER2 Metastatic breast ...

Ann Marie Rogers won a landmark victory to make the breast cancer drug Herceptin more widely available. Here, she explains what drove her. But others are asking if the treatment really lives up to ...

Trastuzumab Emtansine Improves Long ... that uses engineered fat cells to deprive ... Inhibitor Drugs to Treat Aggressive Breast Cancer Identified Feb. 3, 2025 — A national study seeking more ...